Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia

Goetz, M.; Behre, G.; Heussel, G.; Steinmetz, H. T; Eigler, A.; Hiddemann, W.; Weiss, M.
July 2002
Annals of Hematology;Jun2002, Vol. 81 Issue 7, p382
Academic Journal
Sepsis in chemotherapy-associated neutropenia is a major cause of mortality in the treatment of acute myeloid leukemia (AML). Early diagnosis of sepsis is crucial for patient survival. We analyzed the value of prospectively measuring serum concentrations of soluble tumor necrosis factor receptor type II (sTNF-RII) in patients with AML for early diagnosis of sepsis in neutropenia. Therefore, 54 adult patients with AML and neutropenia were followed around the onset of fever. A total of 59 febrile episodes were documented. We could not demonstrate a significant increase in sTNF-RII levels prior to fever. sTNF-RII concentrations were not predictive of the severity of a febrile episode. Based on these data, we cannot recommend the routine screening of sTNF-RII for early detection of septic complications in patients undergoing cytoreductive therapy of AML.


Related Articles

  • Adalimumab.  // Reactions Weekly;May2014, Vol. 1499 Issue 1, p5 

    An abstract of the article "Rocky Mountain Spotted Fever in a patient treated with anti-TNF-alpha inhibitors," by R. M. Mays and colleagues is presented.

  • A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Dunstan, Sarah J.; Nguyen Thi Hue; Rockett, Kirk; Forton, Julian; Morris, Andrew P.; Diakite, Mahamadou; Mai Ngoc Lanh; Le Thi Phuong; House, Deborah; Parry, Christopher M.; Vinh, Ha; Hieu, Nguyen T.; Dougan, Gordon; Tran Tinh Hien; Kwiatowski, Dominic; Farrar, Jeremy J. // Human Genetics;Aug2007, Vol. 122 Issue 1, p51 

    The genomic region surrounding the TNF locus on human chromosome 6 has previously been associated with typhoid fever in Vietnam (Dunstan et al. in J Infect Dis 183:261–268, ). We used a haplotypic approach to understand this association further. Eighty single nucleotide polymorphisms...

  • Diagnostic Relevance of Interleukin-6 and Tumor Necrosis Factor Alpha in Discriminating High Risk and Low Risk Groups in Febrile Patients with Neutropenia. Parsa, M.; Najafi, S. N.; Jafari, N. Jonaidi; Mohraz, M.; Ghavamzadeh, A.; Bahar, B.; Izadi, M.; Radar, M. H.; Ghofrani, H. // Journal of Biological Sciences;2007, Vol. 7 Issue 2, p338 

    The present study was designed to determine diagnostic value of IL-6 and TNF-α in patients with fever and neutropenia. This is a prospective study of 133 patients admitted to two university hospital in Tehran, Iran with fever and neutropenia. Patients were divided two groups as low risk and...

  • Ultra-Low-Dose Chest CT in Patients with Neutropenic Fever and Hematologic Malignancy: Image Quality and Its Diagnostic Performance. Hae Jin Kim; So Young Park; Ho Yun Lee; Kyung Soo Lee; Kyung Eun Shin; Jung Won Moon // Cancer Research & Treatment;2014, Vol. 46 Issue 4, p393 

    Purpose The aim of this study was to evaluate the image quality of ultra-low-dose computed tomography (ULDCT) and its diagnostic performance in making a specific diagnosis of pneumonia in febrile neutropenic patients with hematological malignancy. Materials and Methods ULDCT was performed...

  • Treatment of Patients with Hematologic Neoplasm, Fever, and Neutropenia. Sepkowitz, Kent A. // Clinical Infectious Diseases;4/1/2005 Supplement, Vol. 40, pS253 

    Choices of empirical antibiotic therapy for patients with febrile neutropenia must be made with very little information about the source and site of infection. The clinician is aided by recognition of the subtle signs and symptoms of infection in immunocompromised patients. National guidelines...

  • Sunitinib.  // Reactions Weekly;5/18/2013, Issue 1453, p39 

    The article presents a case study of a 69-year-old man with anaemia, neutropenia, and fatigue which developed during treatment with sunitinib for Fuhrman grade 4 clear cell renal cell carcinoma with a sarcomatoid component.

  • Circulating E-selectin and tumor necrosis factor-α in extraarticular involvement and joint disease activity in rheumatoid arthritis. Corona-Sanchez, Esther G.; Gonzalez-Lopez, Laura; Muñoz-Valle, Jose F.; Vazquez-Del Mercado, Monica; Lopez-Olivo, Maria; Aguilar-Chavez, Erika; Salazar-Paramo, Mario; Loaiza-Cardenas, Carlos; Oregon-Romero, Edith; Navarro-Hernandez, Rosa E.; Gamez-Nava, Jorge I. // Rheumatology International;Jan2009, Vol. 29 Issue 3, p281 

    In this cross-sectional study, we assessed the relationship between circulating TNF-α and E-selectin (sE-selectin) with extraarticular involvement and severity of joint disease in RA. We compared 56 patients who had RA and extraarticular involvement (ExRA) with a group of 84 patients with...

  • Diagnosis of Pulmonary Embolism by Use of Urinary TNFα and its Soluble TNF Receptor I. Taheri, Syde A.; Shenoy, Sadashiv; Murawski, Sandra; Divan, Kishore; Cullin, Julia; Mousa, Shaker // Angiology;Sep1999, Vol. 50 Issue 9, p703 

    The purpose of this clinical study was to determine the concentration of soluble tumor necrosis factor in urine of patients with pulmonary embolism (PE), verses voluntary control individuals. Sixteen patients (ages 24 to 74 years) with diagnosis of PE, documented by ventilation perfusion scan or...

  • Erratum to: Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients. Teixeira, H.; Matias, C.; Magalhães, J.; Lyra, J.; Melo, H.; Jucá, M.; Brito, C.; Lucena-Silva, N.; Magalhães, V. // Supportive Care in Cancer;Oct2014, Vol. 22 Issue 10, p2867 

    A correction to the article "Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients" that was published in a previous issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics